S50 Starving the Muscle: Impaired Angiogenesis in Diabetes

Program: Symposia
Basic Session
Sunday, April 3, 2016: 8:15 AM-9:45 AM
Room 160 (BCEC)
Chair:
Zhenqi Liu, MD, University of Virginia Health System, Charlottesville, VA

Nothing to Disclose: ZL
8:15 AM
Theodore P. Ciaraldi, PhD, Department of Medicine, University of California-San Diego, San Diego, CA
Nothing to Disclose: TPC
8:45 AM
Ayotunde O Dokun, MD PhD, Department of Medicine, Endocrinology and Metabolism, University of Virginia Health System, Charlottesville, VA
Nothing to Disclose: AOD
9:15 AM
George L King, MD, Vascular Cell Biology, Joslin Diabetes Center / Harvard Medical School, Boston, MA
Disclosures:
GLK: Investigator, Sanofi, Investigator, Boehringer Ingelheim.
See more of: Symposia

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire